Genoa Ventures | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Genoa Ventures/Activity

Genoa Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

Led Hermes Biosciences' seed round to develop a benchtop extracellular-vesicle isolation system for precision medicine.

Hermes Biosciences

Hermes Biosciences Genoa Ventures

businesswire.comNOV 18, 2025

NOV 18, 2025

Investment

Participated as an existing investor in Aqtual's $31M Series B for its cell-free DNA precision-medicine platform.

Aqtual

Aqtual Genoa Ventures

businesswire.comJUL 10, 2025

JUL 10, 2025

Team Change

Promoted Landon Merrill from Principal to Partner, joining Jenny Rooke and Vikram Chaudhery as investing partners.

Landon Merrill promoted to Partner

businesswire.comOCT 22, 2024

OCT 22, 2024

New Fund

Closed an oversubscribed $84M Fund II, continuing early-stage investing in research tools, diagnostics, Agri/Food Bio, and industrial bio.

Fund II

genoavc.comJUL 2022

JUL 2022